Terms: = Leukemia AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Clinical Outcome
7 results:
1. Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer.
Ferrari N; Mohammed ZM; Nixon C; Mason SM; Mallon E; McMillan DC; Morris JS; Cameron ER; Edwards J; Blyth K
PLoS One; 2014; 9(6):e100759. PubMed ID: 24967588
[TBL] [Abstract] [Full Text] [Related]
2. Low PIP4K2B expression in human breast tumors correlates with reduced patient survival: A role for PIP4K2B in the regulation of E-cadherin expression.
Keune WJ; Sims AH; Jones DR; Bultsma Y; Lynch JT; Jirström K; Landberg G; Divecha N
Cancer Res; 2013 Dec; 73(23):6913-25. PubMed ID: 24127122
[TBL] [Abstract] [Full Text] [Related]
3. Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and leukemia Group B 40101.
Shulman LN; Cirrincione CT; Berry DA; Becker HP; Perez EA; O'Regan R; Martino S; Atkins JN; Mayer E; Schneider CJ; Kimmick G; Norton L; Muss H; Winer EP; Hudis C
J Clin Oncol; 2012 Nov; 30(33):4071-6. PubMed ID: 22826271
[TBL] [Abstract] [Full Text] [Related]
4. Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.
Mukherjee K; Chakravarthy AB; Goff LW; El-Rifai W
Dig Dis Sci; 2010 Dec; 55(12):3304-14. PubMed ID: 20300841
[TBL] [Abstract] [Full Text] [Related]
5. Targeted therapies in gynecologic cancers.
Chon HS; Hu W; Kavanagh JJ
Curr Cancer Drug Targets; 2006 Jun; 6(4):333-63. PubMed ID: 16848724
[TBL] [Abstract] [Full Text] [Related]
6. Comparison of her2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.
Dressler LG; Berry DA; Broadwater G; Cowan D; Cox K; Griffin S; Miller A; Tse J; Novotny D; Persons DL; Barcos M; Henderson IC; Liu ET; Thor A; Budman D; Muss H; Norton L; Hayes DF
J Clin Oncol; 2005 Jul; 23(19):4287-97. PubMed ID: 15994142
[TBL] [Abstract] [Full Text] [Related]
7. Overexpression of her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.
Chevallier P; Robillard N; Wuilleme-Toumi S; Méchinaud F; Harousseau JL; Avet-Loiseau H
Haematologica; 2004 Nov; 89(11):1399-401. PubMed ID: 15531467
[TBL] [Abstract] [Full Text] [Related]
